Analyst Ratings for CytoMed Therapeutics (GDTC)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/21/2023 | Benchmark | Bruce Jackson | New Coverage | Speculative Buy (N/A) |
5.00 (N/A) |
3.85 (1.05) |
-72.73% | Details |
